There are an estimated 3 million tympanostomy tubes used per year for children with chronic otitis media with effusion (COME) and acute otitis media (AIM). Otomagnetics has developed a system to instead magnetically deliver therapy to cochlear and middle ear compartments, eliminating the need for tubes. NCC-PDI has advised the company and helped with pre-clinical studies on the device.
Year:
2014
Anticipated Classification:
Class II
Anticipated Regulatory Path:
510(k)
Initial Development Stage:
Pre-clinical
Current Development Stage:
Pre-clinical
